A news story earlier this morning incorrectly stated that Zimmer'sNexGen(R) knee implant had been recalled. In fact, the recall notificationcited refers only to a surgical instrument used for minimally invasivesurgeries (MIS) and not the implant system itself. The Company says that therecall is isolated to a single surgical instrument and that additionalinstrumentation options are available. The Company does not expect thisinstrument recall will have a material impact on sales.
Advertisement
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safeharbor provisions of the Private Securities Litigation Reform Act of 1995based on current expectations, estimates, forecasts and projections about theorthopaedics industry, management's beliefs and assumptions made bymanagement. Forward-looking statements may be identified by the use offorward-looking terms such as "may," "will," "expects," "believes,""anticipates," "plans," "estimates," "projects," "assumes," "guides,""targets," "forecasts," and "seeks" or the negative of such terms or othervariations on such terms or comparable terminology. These statements are notguarantees of future performance and involve risks, uncertainties andassumptions that could cause actual outcomes and results to differ materially.These risks and uncertainties include, but are not limited to, our compliancewith the Deferred Prosecution Agreement through March 2009 and the CorporateIntegrity Agreement through 2012, the impact of our enhanced healthcarecompliance global initiatives and business practices on our relationships withcustomers and consultants, our market share and our overall financialperformance, the success of our quality initiatives, the outcome of theinformal investigation by the U.S. Securities and Exchange Commission intoForeign Corrupt Practices Act matters announced in October 2007, price andproduct competition, rapid technological development, demographic changes,dependence on new product development, the mix of our products and services,supply and prices of raw materials and products, customer demand for ourproducts and services, control of costs and expenses, our ability to obtainand maintain adequate intellectual property protection, our ability tosuccessfully integrate acquired businesses, our ability to form and implementalliances, international growth, our compliance with governmental laws andregulations affecting our U.S. and international businesses includingregulations of the U.S. Food and Drug Administration and foreign governmentregulators and tax obligations and risks, product liability and intellectualproperty litigation losses, reimbursement levels from third-party payors,cost-containment efforts of healthcare purchasing organizations, our abilityto retain the independent agents and distributors who market our products,general industry and market conditions and growth rates and general domesticand international economic conditions including interest rate and currencyexchange rate fluctuations. For a further list and description of such risksand uncertainties, see our periodic reports filed with the U.S. Securities andExchange Commission. We disclaim any intention or obligation to update orrevise any forward-looking statements, whether as a result of new information,future events or otherwise, except as may be set forth in our periodicreports. Readers of this document are cautioned not to place undue relianceon these forward-looking statements, since, while we believe the assumptionson which the forward-looking statements are based are reasonable, there can beno assurance that these forward-looking statements will prove to be accurate.This cautionary statement is applicable to all forward-looking statementscontained in this document.
SOURCE Zimmer Holdings, Inc.
